A Comprehensive Overview of Vaccination Against Human Papillomavirus (HPV)

Human Papillomavirus (HPV) is one of the most common sexually transmitted infections in the world, affecting millions of people. This virus is primarily transmitted through skin-to-skin contact and vaginal, anal, or oral sexual intercourse; however, full intercourse is not always required for transmission, and direct skin contact can also lead to contagion. To date, more than 100 types of HPV have been identified, about 30 to 40 of which affect the genital area of both men and women. Research shows that about 80% of sexually active individuals encounter HPV at least once in their lifetime. In most people, the immune system eliminates the virus within a few months to a few years, and the infection remains asymptomatic. However, in some cases, the infection becomes persistent and can pave the way for pre-cancerous lesions and cancer. The most significant cancer associated with HPV is cervical cancer, but the virus is also directly linked to vaginal, vulvar, anal, penile, and oropharyngeal cancers. The importance of HPV vaccination lies in its ability to create effective immunity before exposure to the virus, thereby preventing many of these diseases.

HPV Vaccines

Several types of vaccines have been designed to prevent HPV infection, each providing immunity against specific types of the virus.

Quadrivalent Vaccine (Gardasil-4)

This vaccine provides protection against types 6 and 11, which are the main causes of genital warts, as well as types 16 and 18, which play the most significant role in cervical cancer.

Bivalent Vaccine (Cervarix)

Cervarix creates immunity against types 16 and 18, with its primary focus being the prevention of cervical cancer and pre-cancerous lesions.

Nonavalent Vaccine (Gardasil-9)

Gardasil-9 is the new generation of HPV vaccines that, in addition to the four types in the quadrivalent vaccine, covers five other high-risk types: 31, 33, 45, 52, and 58. This vaccine can prevent over 90% of cervical cancers and about 90% of genital warts.

How does the HPV vaccine work?

The HPV vaccine contains particles that resemble the virus's outer shell, but it does not contain the live or active virus. After injection, the immune system is stimulated and produces antibodies against HPV. If the individual encounters the actual virus in the future, these antibodies prevent the virus from entering cells and causing an infection.

For this reason, the HPV vaccine cannot cause HPV disease or infection.

Vaccine Effectiveness

Studies have shown that HPV vaccines are highly effective. The quadrivalent vaccine is nearly 100% effective in preventing genital warts and pre-cancerous lesions caused by the types included in the vaccine. The bivalent vaccine also has near 100% effectiveness in preventing lesions caused by HPV 16 and 18.

The vaccine is most effective when administered before the onset of sexual activity and prior to contact with the virus. If a person has already been infected with one type of HPV, the vaccine does not treat that specific type, but it can still provide protection against other types covered by the vaccine.

Global Vaccination Recommendations

The Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC) recommend that the HPV vaccine be administered between the ages of 9 and 12. This age is the optimal time to build immunity before exposure to the virus.

Vaccination is recommended for all girls and boys up to age 26. For some individuals between 27 and 45 years of age, vaccination may also be considered based on medical advice and individual circumstances.

Vaccination Schedule

Individuals who begin vaccination before age 15 usually require two doses: - First dose - Second dose 6 to 12 months later If the interval between the two doses is less than 5 months, a third dose will be necessary. For individuals who begin vaccination at age 15 or older, or those who are immunocompromised, a three-dose schedule is recommended: - First dose at month zero - Second dose 1 to 2 months later - Third dose at the sixth month

Vaccination in Men

Although HPV is mostly known for its link to cervical cancer, men are also at risk for the virus's complications. HPV can cause anal, penile, oral, and throat cancers in men. Furthermore, men play a significant role in transmitting the virus to sexual partners. Gardasil-9 is available for men aged 9 to 45 and plays an effective role in preventing genital warts and HPV-related cancers.

Contraindications and Precautions

Individuals who have experienced a severe allergic reaction after a previous vaccine dose should not receive subsequent doses. Also, Gardasil-9 is produced in baker's yeast and is not suitable for individuals with severe yeast allergies.

In the case of a moderate or severe acute illness, vaccination should be postponed until recovery; however, mild illnesses such as a cold are not a barrier to receiving the vaccine.

HPV Vaccine and Pregnancy

HPV vaccination is not recommended during pregnancy, and it is better to delay starting or continuing the vaccination until after childbirth. However, if someone receives the vaccine without knowing they are pregnant, there is no cause for concern, and no evidence of harm to the fetus or any need for pregnancy termination has been reported.

HPV Vaccine Side Effects

The most common side effects of the HPV vaccine occur at the injection site and include: • Pain • Redness • Swelling Some individuals may experience symptoms such as: • Headache • Fatigue • Nausea • Dizziness • Mild fever • Muscle or joint pain These symptoms are usually mild and resolve within a short period. In rare cases, a severe allergic reaction may occur. There is also a possibility of low blood pressure or fainting after the injection; therefore, it is recommended that the individual remains seated or lying down for about 15 minutes after vaccination. Studies have so far shown no dangerous long-term complications from the HPV vaccine.

Common Questions about the HPV Vaccine

Many people mistakenly believe the HPV vaccine is only beneficial for women, while it also protects men against cancers and genital warts. Some parents are concerned that vaccinating adolescents might lead to early initiation of sexual activity, but no scientific study has confirmed this. It should also be noted that the HPV vaccine is not a treatment for an active infection and only prevents new infections. Therefore, even those who have received the vaccine must continue regular screenings, such as Pap smears, because no vaccine provides complete protection against all high-risk HPV types.

Conclusion

HPV vaccination is an effective and safe measure to prevent serious cancers and genital lesions. Vaccination, combined with regular medical screenings, offers the best protection against this common virus. Remember that the vaccine is most effective when administered before potential exposure to the virus, and it is essential to consult with a specialist to discuss the best timing and suitability based on your individual health profile.